ROCK1 directly interacts with and stabilizes the oncogene c-Myc protein leading to the increased oncomir miR-17–92 cluster expression in breast cancer and prostate cancer (Liu et al. 2009; Zhang et al. 2014). Here, ROCK1 is linked to prostate carcinoma.